Skip to main content
Log in

Intranasal Delivery of RS-93522, a Dihydropyridine-Type Calcium-Channel Antagonist

  • Note
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  1. L. Gu. Personal communication, Syntex Research.

  2. A. Hussain, S. Hirai, and R. Bawarshi. Nasal absorption of propanolol in rats. J. Pharm. Sci. 68:1196 (1979).

    Google Scholar 

  3. A. Hussain, T. Foster, S. Hirai, T. Kashihara, R. Batenhorst, and M. Jones. Nasal absorption of propanolol in humans. J. Pharm. Sci. 69:1240 (1980).

    Google Scholar 

  4. A. Hussain, S. Hirai, and R. Bawarshi. Nasal absorption of propanolol from different dosage forms by rats and dogs. J. Pharm. Sci. 69:1411–1413 (1980).

    Google Scholar 

  5. G. F. X. David, C. P. Puri, and T. C. Anand Kumar. Bioavailability of progesterone enhanced by intranasal spraying. Experientia 37:533–534 (1981).

    Google Scholar 

  6. K. S. E. Su, K. M. Campanale, and C. L. Gries. Nasal drug delivery system of a quaternary ammonium compound: Clofilium tosylate. J. Pharm. Sci. 73:1251–1254 (1984).

    Google Scholar 

  7. K. S. E. Su, K. M. Campanale, L. G. Mendelsohn, G. A. Kerchner, and C. L. Gries. Nasal delivery of polypeptides. I. Nasal absorption of enkephalins in rats. J. Pharm. Sci. 74:394–398 (1985).

    Google Scholar 

  8. A. T. Wu, J. Thompson, and I. J. Massey. Specific determination of RS-93522 and its pyridine metabolite in plasma by HPLC method employing mixed mode separation. Pharm. Res. 3:5S (1986).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cherng-Chi Fu, R., Whatley, J.L. & Fleitman, J.S. Intranasal Delivery of RS-93522, a Dihydropyridine-Type Calcium-Channel Antagonist. Pharm Res 8, 134–135 (1991). https://doi.org/10.1023/A:1015811230038

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015811230038

Navigation